Codman Neuro

[ Editor’s Note: This article was updated on 14 December with additional commentary from securities analysts that arrived after publication of the original version on 13 December. ] Integra LifeSci

[ Editor's Note: Due to a technical issue, some of this article did not appear online when it was originally published on 1 November, so we are republishing it in its entirety. ] Johnson & Johnson

Integra Medical expects the acquisition of regenerative tissue product developer ACell to improve its tissue technologies pipeline and accelerate the company’s overall revenue growth. On 16 December,

The top 100 publicly listed and reportable medical technology companies had global sales spanning from more than $30bn to some $100m in the lower reaches, according to the most recent year of fully re